Related Experiment Videos
[Treatment of hypertension in pregnancy. How long is ambulatory treatment enough?]
1Franz-Volhard-Klinik, Charité, Humboldt-Universität, Berlin. homuth@fvk-berlin.de
Abstract:
Hypertension in pregnancy is diagnosed when pressures in excess of 140/90 mmHg are repeatedly measured. A differentiation is made between pregnancy-independent hypertension, i.e. pre-existing hypertension and gestational hypertension occurring for the first time after the 20th week of the pregnancy. If hypertension is accompanied by proteinuria, the diagnosis of pre-eclampsia is made. Feared complications are eclampsia and the HELLP syndrome. For blood pressure measurement, a number of peculiarities must be noted: thus, for example, in severe pre-eclampsia the circadian rhythm may reverse, with pressure increases in particular in the evening and at night. Ambulatory management may be permissible only in the case of pre-pregnancy and gestational hypertension, provided the blood pressure can be kept below 160/100. Restricting physical activity, and regular monitoring of weight, blood pressure and laboratory investigations usually suffice. If pre-eclampsia or the HELLP syndrome is suspected, the patient should be hospitalized without delay. A hypertensive crisis must prompt immediate measures to lower the blood pressure--but not too quickly, in order to avoid severe consequences for the fetus caused by inadequate uteroplacental perfusion.
Related Concept Videos
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension V: Nursing Management
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension I: Introduction
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...